NCT05000138View on ClinicalTrials.gov

FDG Digital PET/CT as First Line Investigation for Giant Cell Arteritis

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

June 10, 2022

Primary Completion Date

August 25, 2025

Study Completion Date

August 25, 2025

Conditions
Giant Cell ArteritisVasculitis
Interventions
DIAGNOSTIC_TEST

FDG PET/CT

Patients with suspected giant cell arteritis, of which FDG PET/CT is indicated for diagnosis of large vessel involvement, will have the small cranial arteries analyzed for involvement.

Trial Locations (5)

21000

Université Bourgogne Europe, Centre Georges-François Leclerc, Dijon

H4J 1C5

Hôpital du Sacré-Cœur de Montréal, Montreal

H4R3E8

Jewish General Hospital, Montreal

H3T1C5

CHUS, Sherbrooke

Unknown

University Medical Center Groningen, Groningen

All Listed Sponsors
lead

Jewish General Hospital

OTHER